Intellia Therapeutics IncEigentümerstruktur
| Preis (2026-07-29) | 52W Hoch | 52W Tief |
| 10.8 USD | 28,25 USD | 7,95 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 26,167 USD | 18 | 4 | 6 | 1 | 0 |
| #Shares | Short [%] | Short Ratio |
| 139.722.277 | 41,3 | 7,38 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Intellia Therapeutics Inc
Mitarbeiter 377
Handelsplatz NASDAQ
Ticker Symbol NTLA
IPO Datum 2016-05-06
Adresse 40 Erie Street, Cambridge, MA, United States, 02139
Webseite https://www.intelliatx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. John M. Leonard M.D. | President, CEO & Director |
| 2 | Mr. Edward J. Dulac III | Executive VP, CFO & Treasurer |
| 3 | Dr. Birgit Schultes Ph.D. | Executive VP & Chief Scientific Officer |
| 4 | Mr. James E. Basta Esq., J.D. | Executive VP, General Counsel & Corporate Secretary |
| 5 | Dr. David Lebwohl M.D. | Executive VP & Chief Medical Officer |
| 6 | Dr. Rachel E. Haurwitz Ph.D. | Co-Founder |
| 7 | Dr. Jennifer A. Doudna Ph.D. | Founder & Member of Scientific Advisor Board |
| 8 | Dr. Derrick J. Rossi Ph.D. | Founder & Member of Scientific Advisor Board |
| 9 | Dr. Rodolphe Barrangou M.B.A., Ph.D. | Founder & Member of Scientific Advisor Board |
| 10 | Prof. Luciano Marraffini Ph.D. | Founder & Member of Scientific Advisor Board |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | ARK Investment Management LLC | 0,00% | 0,00 Mio. USD |
| 2 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 3 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 4 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 5 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 6 | D. E. Shaw & Co LP | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 9 | Regeneron Pharmaceuticals Inc | 0,00% | 0,00 Mio. USD |
| 10 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 11 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 12 | Two Sigma Advisers, LLC | 0,00% | 0,00 Mio. USD |
| 13 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 14 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 15 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 16 | Amova Asset Management Americas, Inc | 0,00% | 0,00 Mio. USD |
| 17 | Sumitomo Mitsui Trust Group Inc | 0,00% | 0,00 Mio. USD |
| 18 | Contrarius Group Holdings Ltd | 0,00% | 0,00 Mio. USD |
| 19 | Jupiter Asset Management Limited | 0,00% | 0,00 Mio. USD |
| 20 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |